Objective To study the cellular mechanism of the effect of Ang Ⅱ on ICa,L in single guinea-pig ventricular cells by using losartan and 1-(5-Isoquinolinylsulfonyl)-2-Methyl-Piperazine (H-7) as the Ang Ⅱ type 1 recep...Objective To study the cellular mechanism of the effect of Ang Ⅱ on ICa,L in single guinea-pig ventricular cells by using losartan and 1-(5-Isoquinolinylsulfonyl)-2-Methyl-Piperazine (H-7) as the Ang Ⅱ type 1 receptor (AT1) inhibitor and protein kinase C inhibitor, respectively.Methods Patch clamp techniques were used to study the cellular mechanism of the effect of Ang Ⅱ on ICa,L in single guinea-pig ventricular cells.Results In the whole cell patch clamp recording model, Ang Ⅱ stimulated ICa,L in a concentration dependent manner; the maximal effect was obtained at 100?nmol/L (n=9). At 30?nmol/L, Ang Ⅱ stimulated peak ICa,L from 11.3±0.6?pA/pF to 15.3±0.6?pA/pF (at +10?mV, n=9, P<0.05). 100?nmol/L Losartan, a specific AT1 receptor inhibitor, had no effect on ICa,L (n=9), but the effect of Ang Ⅱ on ICa,L was inhibited by 100?nmol/L Losartan. Ang Ⅱ on ICa,L was also inhibited by 20?μmol/L H-7, a specific protein kinase C inhibitor, whereas H-7 alone has no effect on ICa,L (n=9).Conclusion Ang Ⅱ stimulates ICa,L in guinea-pig ventricular cells by binding to AT1 through a transduction pathway involving protein kinase C.展开更多
文摘Objective To study the cellular mechanism of the effect of Ang Ⅱ on ICa,L in single guinea-pig ventricular cells by using losartan and 1-(5-Isoquinolinylsulfonyl)-2-Methyl-Piperazine (H-7) as the Ang Ⅱ type 1 receptor (AT1) inhibitor and protein kinase C inhibitor, respectively.Methods Patch clamp techniques were used to study the cellular mechanism of the effect of Ang Ⅱ on ICa,L in single guinea-pig ventricular cells.Results In the whole cell patch clamp recording model, Ang Ⅱ stimulated ICa,L in a concentration dependent manner; the maximal effect was obtained at 100?nmol/L (n=9). At 30?nmol/L, Ang Ⅱ stimulated peak ICa,L from 11.3±0.6?pA/pF to 15.3±0.6?pA/pF (at +10?mV, n=9, P<0.05). 100?nmol/L Losartan, a specific AT1 receptor inhibitor, had no effect on ICa,L (n=9), but the effect of Ang Ⅱ on ICa,L was inhibited by 100?nmol/L Losartan. Ang Ⅱ on ICa,L was also inhibited by 20?μmol/L H-7, a specific protein kinase C inhibitor, whereas H-7 alone has no effect on ICa,L (n=9).Conclusion Ang Ⅱ stimulates ICa,L in guinea-pig ventricular cells by binding to AT1 through a transduction pathway involving protein kinase C.
基金supported by the National Natural Science Foundation of China(No.30572193)the Specialized Research Fund for the Doctoral Program of Higher Education of China(No.20050316009)
文摘本文旨在研究L-甲状腺素(L-thyroxine,L-thy)所致的大鼠心肌病模型上血流动力学及心室肌细胞钠电流(INa)、L-钙通道电流(ICa-L)的变化。实验大鼠随机分成两组:心肌病组和对照组。心肌病组以0.5mg/kg腹腔注射L-thy,连续注射10d,建模成功后测定血流动力学变化,然后急性酶解法分离心肌细胞,应用全细胞膜片钳技术记录心肌细胞INa和ICa-L。结果显示:(1)与对照组相比,心肌病组大鼠左心室收缩压(leftventricular systolic pressure,LVSP)、左心室发展压(left ventricular developed pressure,LVDP)和左心室舒张期室内压最大下降速率(-dp/dtmax)均显著降低(P<0.01),左心室收缩期室内压最大上升速率(+dp/dtmax)也表现为降低(P<0.05),左心室舒张末期压(left ventricular end-diastolic pressure,LVEDP)显著升高(P<0.01);(2)与对照组相比,在去极化电位为-30mV时,心肌病组大鼠心肌细胞INa电流密度由(-21.1±6.3)pA/pF增大至(-26.2±3.2)pA/pF(n=12,P<0.01),INa的激活曲线左移,失活曲线左移,去失活曲线右移;(3)与对照组相比,在去极化电位为-10mV时,心肌病组大鼠心肌细胞ICa-L电流密度由(-5.4±0.6)pA/pF增至(-7.9±0.8)pA/pF(n=12,P<0.01),ICa-L的激活曲线左移,失活曲线左移,去失活曲线左移。以上结果表明,甲状腺素心肌病模型心功能与心力衰竭相似,其INa和ICa-L功能明显增强,尤其是ICa-L,提示在INa和ICa-L功能异常增强的心肌病治疗中若使用的钙通道拮抗剂带有降低心肌对Na+通透性的药物效果应更佳。